We take cases on a No Win, No Fee basis, which means we don't get paid unless we recover your claim.

J&J Expands Recall on Tylenol

January 15, 2010

New Brunswick - US pharmaceutical giant Johnson & Johnson has expanded the recall on its over-the-counter Tylenol products. Last November, the company and health regulators also recalled Tylenol Arthritis Caplets over the presence of molds which can cause severe diarrhea, vomiting, stomach pain, and nausea.

In its press release, the company said the recall now includes eight-hour Tylenol, children’s Tylenol, Tylenol PM, Tylenol arthritis, Motrin IB, children’s Motrin, Simply Sleep, Benadryl Rolaids, and St. Joseph’s aspirin.

Meanwhile, geltab and caplet products sold in Fiji, United Arab Emirates, North, and South Americas are also covered by the recall.

Despite its recall announcement, the company has been criticized by health regulators for failing to address the issue in early 2008 when it has first discovered the problem.

In a statement, the US Food and Drug Administration (FDA) said that Johnson & Johnson “should have acted faster” to prevent consumers from getting sick.

“Companies must immediately investigate and take all the necessary action if they notice any problems with their products”, Debor Autor, FDA’s director for Office of Compliance of the Center for Drug Evaluation and Research said in an interview.

Recently, FDA officials sent a warning letter to the company for violating the federal manufacturing standards and failing to immediately report the problem to health regulators. The federal agency has received 70 reported cases of people getting sick after taking Tylenol products.